Evaluation of the Effect of a Combination of Plant Extracts (BSL_EP027) on the Incidence of Respiratory Infections
NCT ID: NCT04386408
Last Updated: 2020-05-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1
60 participants
INTERVENTIONAL
2019-11-30
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Aromatherapy for Upper Respiratory Health
NCT06190379
The Effects of Heated Tobacco Products Use on Lung Function and Volatile Organic Compounds in Exhaled Air
NCT05260827
Cough Responses to Tussive Agents in Health and Disease
NCT01297790
Smoker Extracellular Vesicles Influence on Human Bronchial Epithelial Cells
NCT03608293
Woodsmoke Exposure and Cardiovascular Function
NCT01488500
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Traditionally, protection against infection and improvement of the immune response has been addressed through the use of plant extracts. An effective immune response involves the action of both innate and specific responses and the perfect coordination between both. Natural strategies that can activate both types of immune response can lead to more effective treatments.
Our hypothesis is that the different effects of the combination of several plant extracts can lead to a synergy that generates a more effective product in the prevention of respiratory infections, especially in susceptible populations such as the elderly.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Combination of plant extracts (BSL_EP027)
Volunteers will dissolve in water a sachet per day with the Combination of plant extracts (BSL\_EP027), and maltodextrin.
Combination of plant extracts (BSL_EP027)
Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life.
Placebo
Volunteers will dissolve in water a sachet per day with maltodextrin.
Placebo
Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Combination of plant extracts (BSL_EP027)
Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life.
Placebo
Each participant will consume a sachet disolve in water once at day without any restriction in the diet nor in their habits of life.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Freely accept to participate in the study and sign the informed consent document.
Exclusion Criteria
* Suffer alterations of the state of health incompatible with the continuity in the study.
* Suffer any adverse event not tolerated by the subject.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Biosearch S.A.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlos Gracián, MD
Role: PRINCIPAL_INVESTIGATOR
Doctor of the Claret Nursing Home (Granada, Spain)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Claret Nursing home
Granada, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.